1. Home
  2. NAUT

as 06-20-2025 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Industrials

Biotechnology: Laboratory Analytical Instruments

Nasdaq

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

Founded: 2016 Country:
United States
United States
Employees: N/A City: SEATTLE
Market Cap: 91.5M IPO Year: N/A
Target Price: $3.88 AVG Volume (30 days): 207.1K
Analyst Decision: Hold Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.55 EPS Growth: N/A
52 Week Low/High: $0.66 - $3.09 Next Earning Date: 07-29-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

NAUT Daily Stock ML Predictions

Stock Insider Trading Activity of Nautilus Biotechnolgy Inc. (NAUT)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Mowry Anna NAUT CFO and Treasurer May 29 '25 Buy $0.77 15,000 $11,488.50 83,000
Mallick Parag NAUT Chief Scientist May 8 '25 Buy $0.73 13,500 $9,885.15 20,491,892

Share on Social Networks: